Iradimed (IRMD) Return on Capital Employed Growth (3y) (2017 - 2026)
Iradimed (IRMD) Return on Capital Employed Growth (3y) (2017 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | ROCE Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 199.46 Bn | 193.86 Bn | 7.27 Bn | -236.00 |
| 2 | Stryker | 127.41 Bn | 123.93 Bn | 4.50 Bn | 281.00 |
| 3 | Medtronic | 118.87 Bn | 109.65 Bn | 6.41 Bn | 145.00 |
| 4 | Boston Scientific | 73.47 Bn | 72.93 Bn | 3.85 Bn | 446.00 |
| 5 | Edwards Lifesciences | 51.95 Bn | 47.69 Bn | 1.35 Bn | -433.00 |
| 6 | Dexcom | 34.30 Bn | 32.35 Bn | 830.00 Mn | 1,627.00 |
| 7 | GE HealthCare Technologies | 33.76 Bn | 31.65 Bn | 2.18 Bn | -62.00 |
| 8 | Koninklijke Philips | 26.35 Bn | 23.02 Bn | 4.55 Bn | - |
| 9 | Steris | 23.04 Bn | 22.55 Bn | 684.20 Mn | 370.00 |
| 10 | Iradimed | 1.11 Bn | 1.05 Bn | 15.16 Mn | 165.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 165.00 |
| Mar 31, 2026 | 567.00 |
| Dec 31, 2025 | 462.00 |
| Sep 30, 2025 | 531.00 |
| Jun 30, 2025 | 521.00 |
| Mar 31, 2025 | 917.00 |
| Dec 31, 2024 | 1,172.00 |
| Sep 30, 2024 | 1,496.00 |
| Jun 30, 2024 | 1,882.00 |
| Mar 31, 2024 | 2,477.00 |
| Dec 31, 2023 | 2,842.00 |
| Sep 30, 2023 | 2,371.00 |
| Jun 30, 2023 | 2,042.00 |
| Mar 31, 2023 | 988.00 |
| Dec 31, 2022 | 642.00 |
| Sep 30, 2022 | 494.00 |
| Jun 30, 2022 | 574.00 |
| Mar 31, 2022 | 172.00 |
| Dec 31, 2021 | -68.00 |
| Sep 30, 2021 | -260.00 |